Sato Y, Ohta Y, Ohtsuka T, Shoji H, Oizumi K
First Department of Internal Medicine, Kurume University School of Medicine.
Rinsho Shinkeigaku. 1991 Feb;31(2):175-8.
A 44-year-old male was admitted for diplopia, headache and gait disturbance. Neurological examination revealed the meningeal irritation sign, the Vth, VII, VIth, IXth and the Xth nerve palsies and cerebellar ataxia of all four limbs. Laboratory studies carried out on the day of admission demonstrated the elevation of serum levels of both tumor markers, carbohydrate 19-9 (CA19-9) and carcinoembryonic antigen (CEA). The estimated serum concentrations of CA19-9 and CEA were 39.4 U/ml and 81.1 ng/ml, respectively. The cerebrospinal fluid (CSF) contained 9 cells/mm3 which consisted of the mixture of malignant cells with appearance strongly suggestive of poorly differentiated adenocarcinoma and of hemosiderinphagocytizing macrophages. Detection of both CA19-9 and CEA in the tumor cells in the CSF was undertaken by the avidin biotinylated peroxidase complex method by use of monoclonal antibodies against each marker. As the results the following findings were obtained. Namely, although all the tumor cells isolated from the CSF were found to contain both tumor markers, CA19-9 and CEA, there was found a difference in the concentration ratio in CSF vs serum between the markers. The estimated concentration of CA19-9 (61.4 U/ml) in CSF was approximately 1.6 times higher than that in serum. On the other hand, the CSF concentration of CEA remained constantly very low (1.1 ng/ml) as compared with that in the serum throughout the whole course of the disease. In response to intrathecal administration of cytarabine and brain irradiation, the CSF cytological findings became normal and concomitant decrease in the concentration of CA19-9 was demonstrated.(ABSTRACT TRUNCATED AT 250 WORDS)
一名44岁男性因复视、头痛和步态障碍入院。神经系统检查发现有脑膜刺激征、第Ⅴ、Ⅶ、Ⅵ、Ⅸ和第Ⅹ对脑神经麻痹以及四肢小脑性共济失调。入院当天进行的实验室检查显示两种肿瘤标志物,即糖类抗原19-9(CA19-9)和癌胚抗原(CEA)的血清水平升高。CA19-9和CEA的估计血清浓度分别为39.4 U/ml和81.1 ng/ml。脑脊液(CSF)中每立方毫米含有9个细胞,由恶性细胞与外观强烈提示低分化腺癌的细胞以及含铁血黄素吞噬巨噬细胞混合而成。通过使用针对每种标志物的单克隆抗体,采用抗生物素蛋白生物素化过氧化物酶复合物法对脑脊液中的肿瘤细胞进行CA19-9和CEA检测。结果如下。即,虽然从脑脊液中分离出的所有肿瘤细胞均发现含有CA19-9和CEA这两种肿瘤标志物,但发现这两种标志物在脑脊液与血清中的浓度比存在差异。脑脊液中CA19-9的估计浓度(61.4 U/ml)约为血清中的1.6倍。另一方面,在疾病的整个过程中,脑脊液中CEA的浓度与血清相比一直非常低(1.1 ng/ml)。鞘内注射阿糖胞苷和脑部放疗后,脑脊液细胞学检查结果恢复正常,同时CA19-9浓度也随之降低。(摘要截断于250字)